Roger Miller

Roger Miller is an experienced pharmaceutical and biotechnology executive with broad general management experience. He joined Apexian as the Chief Operating Officer in November 2014.

Roger started his career with Eli Lilly and Company in research and development as an physical chemist before transitioning into a variety of general management roles in operations, human resources, manufacturing, and quality. He also had the opportunity to build the technical due diligence processes supporting technology assessments for Lilly’s business development organization. Roger has held significant leadership positions across a variety of biotechnology companies and start-ups, including Chief Operating Officer at Targanta Therapeutics, developing gram positive anti-infective agents; Vice President of Development for Beta Cat and Salarius Pharmaceuticals, developing oncolytic agents for colon cancer; and Chief Operating Officer at BioCritica, developing therapeutics for the critical care hospital setting.

Roger received both B.A. and M.S. degrees in chemistry from Indiana University (IUPUI). When his career moved into general management at Lilly, he obtained a M.S. degree in management (MBA) from Purdue Krannert Graduate School of Management.